Status: Recruiting
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
To determine whether the Peschke PXL-330 system is safe and effective in the treatment of corneal thinning conditions.
Participants needed: 300
Trial details
Phase: Phase 1Age: 12-45Biological sex: AllType: InterventionalSponsor: Pacific Clear Vision InstituteUpdated: Nov 12, 2024Locations: 1
Eligibility criteria
12 years of age or older [+26]
Eyes classified as either normal or atypical normal on the severity grading sche... [+8]